Published: 12/15/2020 21:11 GMT Phathom Pharmaceuticals Inc (PHAT) - Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock.
Phathom Pharmaceuticals Inc - Intends to Use Net Proceeds From Proposed Offering to Fund Clinical Development of Vonoprazan.